Laboratory Corporation of America(R) Holdings Announces 2007 First Quarter Results

First Quarter Net Sales Growth of 13.7% Drives Operating Cash Flow of $185.8 Million and EPS Increase of 28.9% BURLINGTON, N.C., April 26 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter ended March 31, 2007.

Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Essays

ROCKVILLE, Md. and BURLINGTON, N.C., April 25 /PRNewswire-FirstCall/ -- Celera (NYSE: CRA), an Applera Corporation business, and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), a national leader in esoteric and oncology testing, today announced that they have signed an

Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., April 16 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may

LabCorp's Liquid Yield Option(TM) Notes Due 2021 And Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Cash Interest

BURLINGTON, N.C., March 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that for the period of March 12, 2007 to September 11, 2007, its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021

LabCorp is Scheduled to Present at the Lehman Brothers 2007 Global Healthcare Conference

BURLINGTON, N.C., March 19, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and

LabCorp Announces $500 Million Stock Repurchase Program

BURLINGTON, N.C., March 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Board of Directors has authorized a new stock repurchase program under which LabCorp may purchase up to an aggregate of $500,000,000 of its Common

LabCorp is Scheduled to Present at the Cowen and Company 27th Annual Health Care Conference

BURLINGTON, N.C., March 12 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and Bradford T.

LabCorp(R) Notified by Aetna of Contract Termination

BURLINGTON, N.C., March 1 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), one of the world's leading clinical laboratories, today announced that it will no longer be a contracted laboratory provider for Aetna Inc. (NYSE: AET), effective July 1, 2007.

LabCorp is Scheduled to Present at the Susquehanna Financial Group Significant Investment Options in Healthcare Conference

BURLINGTON, N.C., Feb 28, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and

Laboratory Corporation of America(R) Announces 2006 Fourth Quarter and Full Year Results

Fourth Quarter Net Sales Growth of 9.3% Drives Operating Cash Flow of $170.2 million and EPS Increase of 26.6% BURLINGTON, N.C., Feb 15, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the